Johns Hopkins University School of Medicine
Baltimore, Maryland, 21224, United States
NCT Number: NCT00000324
The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 2
Baltimore, Maryland, 21224, United States
This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention model of treatment intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
National Institute on Drug Abuse (NIDA)
Nih
Tryptophan and Behavior Therapy for Cocaine Abuse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02037126
Chemically-Induced Disorders, Cocaine-Related Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT04155632
Chemically-Induced Disorders, Cocaine-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT02773212
Anhedonia, Chemically-Induced Disorders
Chicago, Illinois, United States
View Trial DetailsNCT03953612
Chemically-Induced Disorders, Cocaine-Related Disorders
New Haven, Connecticut, United States
View Trial Details